Back

Effects of cyborg-type robot suit HAL on cardiopulmonary burden during exercise in normal subjects

20 April 2018 (09:45 - 10:00)
Organised by:
Congress Presentation Part of: Young investigator award session III - Exercise Basic & Translational Research (EBTR) Exercise Testing EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Doctor Yo Joon Pak

Tsukuba University Hospital, Tsukuba (Japan)

5 More presentations in this session

Presentation thumbnail
What is best for women? The effects of aerobic interval training and moderate-intensity continuous exercise on physical and mental health in women with heart disease
Professor J. Reed (Ottawa, CA)
Abstract
Presentation thumbnail
The relation between insulin resistance on longitudinal changes in left ventricular structure and function in a general population.
Mr N. Cauwenberghs (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Moderate walking speed predicts 3-years hospitalisation in hypertensive patients with cardiovascular disease
Doctor C. Merlo (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
Increased heart rate does not explain the cardiac Troponin increase following strenous exercise - the NEEDED 2014 advanced heart rate monitor substudy
Doctor M. Bjorkavoll-Bergseth (Stavanger, NO)
Abstract Slides Video
Presentation thumbnail
Predictors of response to exercise training in patients with coronary artery disease: a subanalysis of the SAINTEX-CAD study
Doctor I. Witvrouwen (Edegem, BE)
Abstract

Access the full session

Session thumbnail
Young investigator award session III - Exercise Basic & Translational Research (EBTR)

The Event

Event poster

EuroPrevent 2018

20 April 2018 09:45 CET
You may be interested in
thumbnail
Congress Session
How to prescribe exercise for people with valvular heart disease or hypertension
thumbnail
Congress Session
Challenges in sports eligibility: what to do with…
thumbnail
Congress Session
May I perform sport a if I have...

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources